Intravenous Solution Market was valued USD 10.68 Bn in 2021 and is expected to register a CAGR of 7.69% to reach USD 19.31 Billion by 2029. Intravenous (IV) solutions are liquids which should be regulated to a patient directly into the venous circulation. These liquids are sterile liquids which ensure patients during extreme dehydration. There are number of sorts of IV solutions accessible for use in the market. Number of organizations makes packaged intravenous liquids or products or compounds which could be blended with sterile water to set up a solutionfor intravenous administration. The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis.To know about the Research Methodology :- Request Free Sample Report
Intravenous Solution Market Dynamics
Growing incidence rate of severe diseases such ascancer is driving the demand for Total Parenteral Nutrition (TPN), which forms animportant aspect of the treatment. Intravenous nutrition supports to continue quality, keeps up hydration levels in patients, and encourages faster recovery. Cancer prevalence is assessed to develop by 70% for next few decades. This represents an enormous development prospect for the market. Number of patients suffering from advanced cancer developsanorexia, thisdecreases their life duration time. These patients don't react well to chemotherapy and suffer from elevated toxicity. This sickness is relieved by peripheral or overall parenteral nutrition. Thus, the rise in use of parenteral nutrition by malignancy patients has driven the development of the IV solutions market.North America accounts for major shareholder of IV solutions in the healthcare industry. The high development rate in this region is recognized by the factors, for example, high IV utilization number around 750 units of typical saline are used every minute in this region. Europe currently holds the second biggest market share of IV solutions industry. The market is developing in this region because of the factors like expanding volume sales of IV solutions in Europe owing to rising European elderlypopulation and relating growth of the patient pool. Healthcare industry is quickly moving to Asia-Pacific from different areas such as North America and Europe. The principle factors for this incorporate, persistently expanding population base alongside the cost advantage, the increase in high-caliber and better healthcare infrastructure and institutions in these nations and rising private assets, and government activities in the region are contributing to the growth of the market. The objective of the report is to present a comprehensive analysis of the Intravenous Solution Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Intravenous Solution Market dynamics, structure by analyzing the market segments and projects the Intravenous Solution Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Intravenous Solution Market make the report investor’s guide.
Intravenous Solution Market Scope: Inquire before buying
Global Intravenous Solution Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: 10.68 Bn. Forecast Period 2022 to 209 CAGR: 7.69% Market Size in 2029: US $ 19.31 Bn. Segments Covered: by Type • Total Parenteral Nutrition (TPN) • Peripheral Parenteral Nutrition (PPN) by Nutrients • Carbohydrates • Single dose amino acid solution • Vitamins & minerals (salt and electrolyte) • Parenteral lipid emulsion • Others (trace elements) by Application • Basic IV Solution • Nutritional IV Solution • Blood IV Solution • Drug IV Solution • Irrigation IV Solution • Others by End-User • Hospitals • Ambulatory Surgery Centers • Home Care Settings Intravenous Solution Market, by Region
• Asia Pacific • North America • Europe • South America • Middle East & AfricaIntravenous Solution Market Key Players:
• Baxter, • Fresenius Kabi AG, • B. Braun Melsungen AG, • ICU Medical, Inc., • Grifols, • Terumo Corporation, • Amanta Healthcare, • Ajinomoto, • Johnson & Johnson , • Novartis AG • Abbott Laboratories • Medtronic PLC • Danaher Corporation • General Electric • 3M Company • Siemens Healthineers • Stryker Corporation • Becton, Dickinson & Company • Intuitive Surgical Inc. • Allergan PLC • Hoya Corp. Frequently Asked Questions: 1. Which region has the largest share in Global Intravenous Solution Market Market? Ans: Asia Pacific region holds the highest share in 2021. 2. What is the growth rate of Global Intravenous Solution Market Market? Ans: The Global Intravenous Solution Market Market is growing at a CAGR of 7.69% during forecasting period 2022-2029. 3. What is scope of the Global Intravenous Solution Market market report? Ans: Global Intravenous Solution Market Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Intravenous Solution Market market? Ans: The important key players in the Global Intravenous Solution Market Market are – Baxter,, Fresenius Kabi AG,, B. Braun Melsungen AG,, ICU Medical, Inc.,, Grifols,, Terumo Corporation,, Amanta Healthcare,, Ajinomoto,, Johnson & Johnson ,, Novartis AG, Abbott Laboratories, Medtronic PLC, Danaher Corporation, General Electric, 3M Company, Siemens Healthineers, Stryker Corporation, Becton, Dickinson & Company, Intuitive Surgical Inc., Allergan PLC, and Hoya Corp. 5. What is the study period of this market? Ans: The Global Intravenous Solution Market Market is studied from 2021 to 2029.
To know about the Research Methodology :- 
North America accounts for major shareholder of IV solutions in the healthcare industry. The high development rate in this region is recognized by the factors, for example, high IV utilization number around 750 units of typical saline are used every minute in this region. Europe currently holds the second biggest market share of IV solutions industry. The market is developing in this region because of the factors like expanding volume sales of IV solutions in Europe owing to rising European elderlypopulation and relating growth of the patient pool.
Healthcare industry is quickly moving to Asia-Pacific from different areas such as North America and Europe. The principle factors for this incorporate, persistently expanding population base alongside the cost advantage, the increase in high-caliber and better healthcare infrastructure and institutions in these nations and rising private assets, and government activities in the region are contributing to the growth of the market.
The objective of the report is to present a comprehensive analysis of the Intravenous Solution Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding Intravenous Solution Market dynamics, structure by analyzing the market segments and projects the Intravenous Solution Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Intravenous Solution Market make the report investor’s guide.
Intravenous Solution Market
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Intravenous Solution Market Size, by Market Value (US$ XX Bn) by 2029 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Intravenous Solution Market Analysis and Forecast 6.1. Intravenous Solution Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Intravenous Solution Market Analysis and Forecast, By Application 7.1. Introduction and Definition 7.2. Key Findings 7.3. Intravenous Solution Market Value Share Analysis, By Application 7.4. Intravenous Solution Market Size (US$ Bn) Forecast, By Application 7.5. Intravenous Solution Market Analysis, By Application 7.6. Intravenous Solution MarketAnalysis, By Application 8. Intravenous Solution Market Analysis and Forecast, By Type 8.1. Introduction and Definition 8.2. Key Findings 8.3. Intravenous Solution Market Value Share Analysis, By Type 8.4. Intravenous Solution Market Size (US$ Bn) Forecast, By Type 8.5. Intravenous Solution Market Analysis, By Type 8.6. Intravenous Solution Market Attractiveness Analysis, By Type 9. Intravenous Solution Market Analysis and Forecast, By End-user 9.1. Introduction and Definition 9.2. Key Findings 9.3. Intravenous Solution Market Value Share Analysis, By End-user 9.4. Intravenous Solution Market Size (US$ Bn) Forecast, By End-user 9.5. Intravenous Solution Market Analysis, By End-user 9.6. Intravenous Solution Market Attractiveness Analysis, By End-user 10. Intravenous Solution Market Analysis and Forecast, By Nutrients 10.1. Introduction and Definition 10.2. Key Findings 10.3. Intravenous Solution Market Value Share Analysis, By Nutrients 10.4. Intravenous Solution Market Size (US$ Bn) Forecast, By Nutrients 10.5. Intravenous Solution Market Analysis, By Nutrients 10.6. Intravenous Solution Market Attractiveness Analysis, By Nutrients 11. Intravenous Solution Market Analysis, by Region 11.1. Intravenous Solution Market Value Share Analysis, by Region 11.2. Intravenous Solution Market Size (US$ Bn) Forecast, by Region 11.3. Intravenous Solution Market Attractiveness Analysis, By Region 12. North America Intravenous Solution Market Analysis 12.1. Key Findings 12.2. North America Intravenous Solution Market Overview 12.3. North America Intravenous Solution Market Value Share Analysis, By Application 12.4. North America Intravenous Solution Market Forecast, By Application 12.4.1. Basic IV Solution 12.4.2. Nutritional IV Solution 12.4.3. Blood IV Solution 12.4.4. Drug IV Solution 12.4.5. Irrigation IV Solution 12.4.6. Others 12.5. North America Intravenous Solution Market Value Share Analysis, By Type 12.6. North America Intravenous Solution Market Forecast, By Type 12.6.1. Total Parenteral Nutrition (TPN) 12.6.2. Peripheral Parenteral Nutrition (PPN) 12.6.3. Others 12.7. North America Intravenous Solution Market Value Share Analysis, By Nutrients 12.8. North America Intravenous Solution Market Forecast, By Nutrients 12.8.1. Carbohydrates 12.8.2. Single dose amino acid solution 12.8.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 12.9. North America Intravenous Solution Market Value Share Analysis, By End-user 12.10. North America Intravenous Solution Market Forecast, By End-user 12.10.1. Hospitals 12.10.2. Ambulatory Surgery Centers 12.10.3. Home Care Settings 12.11. North America Intravenous Solution Market Value Share Analysis, by Country 12.12. North America Intravenous Solution Market Forecast, by Country 12.12.1. U.S. 12.12.2. Canada 12.13. U.S. Intravenous Solution Market Value Share Analysis, By Application 12.14. U.S. Intravenous Solution Market Forecast, By Application 12.14.1. Basic IV Solution 12.14.2. Nutritional IV Solution 12.14.3. Blood IV Solution 12.14.4. Drug IV Solution 12.14.5. Irrigation IV Solution 12.14.6. Others 12.15. U.S. Intravenous Solution Market Value Share Analysis, By Type 12.16. U.S. Intravenous Solution Market Forecast, By Type 12.16.1. Total Parenteral Nutrition (TPN) 12.16.2. Peripheral Parenteral Nutrition (PPN) 12.16.3. Others 12.17. U.S. Intravenous Solution Market Value Share Analysis, By Nutrients 12.18. U.S. Intravenous Solution Market Forecast, By Nutrients 12.18.1. Carbohydrates 12.18.2. Single dose amino acid solution 12.18.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 12.19. U.S. Intravenous Solution Market Value Share Analysis, By End-user 12.20. U.S. Intravenous Solution Market Forecast, By End-user 12.20.1. Hospitals 12.20.2. Ambulatory Surgery Centers 12.20.3. Home Care Settings 12.21. Canada Intravenous Solution Market Value Share Analysis, By Application 12.22. Canada Intravenous Solution Market Forecast, By Application 12.22.1. Basic IV Solution 12.22.2. Nutritional IV Solution 12.22.3. Blood IV Solution 12.22.4. Drug IV Solution 12.22.5. Irrigation IV Solution 12.22.6. Others 12.23. Canada Intravenous Solution Market Value Share Analysis, By Type 12.24. Canada Intravenous Solution Market Forecast, By Type 12.24.1. Total Parenteral Nutrition (TPN) 12.24.2. Peripheral Parenteral Nutrition (PPN) 12.24.3. Others 12.25. Canada Intravenous Solution Market Value Share Analysis, By Nutrients 12.26. Canada Intravenous Solution Market Forecast, By Nutrients 12.26.1. Carbohydrates 12.26.2. Single dose amino acid solution 12.26.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 12.27. Canada Intravenous Solution Market Value Share Analysis, By End-user 12.28. Canada Intravenous Solution Market Forecast, By End-user 12.28.1. Hospitals 12.28.2. Ambulatory Surgery Centers 12.28.3. Home Care Settings 12.29. PEST Analysis 12.30. Key Trends 12.31. Key Developments 13. Europe Intravenous Solution Market Analysis 13.1. Key Findings 13.2. Europe Intravenous Solution Market Overview 13.3. Europe Intravenous Solution Market Value Share Analysis, By Application 13.4. Europe Intravenous Solution Market Forecast, By Application 13.4.1. Basic IV Solution 13.4.2. Nutritional IV Solution 13.4.3. Blood IV Solution 13.4.4. Drug IV Solution 13.4.5. Irrigation IV Solution 13.4.6. Others 13.5. Europe Intravenous Solution Market Value Share Analysis, By Type 13.6. Europe Intravenous Solution Market Forecast, By Type 13.6.1. Total Parenteral Nutrition (TPN) 13.6.2. Peripheral Parenteral Nutrition (PPN) 13.6.3. Others 13.7. Europe Intravenous Solution Market Value Share Analysis, By Nutrients 13.8. Europe Intravenous Solution Market Forecast, By Nutrients 13.8.1. Carbohydrates 13.8.2. Single dose amino acid solution 13.8.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 13.9. Europe Intravenous Solution Market Value Share Analysis, By End-user 13.10. Europe Intravenous Solution Market Forecast, By End-user 13.10.1. Hospitals 13.10.2. Ambulatory Surgery Centers 13.10.3. Home Care Settings 13.11. Europe Intravenous Solution Market Value Share Analysis, by Country 13.12. Europe Intravenous Solution Market Forecast, by Country 13.12.1. U.K. 13.12.2. Germany 13.12.3. France 13.12.4. Italy 13.12.5. Spain 13.12.6. Rest of Europe 13.13. U.K. Intravenous Solution Market Value Share Analysis, By Application 13.14. U.K. Intravenous Solution Market Forecast, By Application 13.14.1. Basic IV Solution 13.14.2. Nutritional IV Solution 13.14.3. Blood IV Solution 13.14.4. Drug IV Solution 13.14.5. Irrigation IV Solution 13.14.6. Others 13.15. U.K. Intravenous Solution Market Value Share Analysis, By Type 13.16. U.K. Intravenous Solution Market Forecast, By Type 13.16.1. Total Parenteral Nutrition (TPN) 13.16.2. Peripheral Parenteral Nutrition (PPN) 13.16.3. Others 13.17. U.K.Intravenous Solution Market Value Share Analysis, By Nutrients 13.18. U.K. Intravenous Solution Market Forecast, By Nutrients 13.18.1. Carbohydrates 13.18.2. Single dose amino acid solution 13.18.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 13.19. U.K. Intravenous Solution Market Value Share Analysis, By End-user 13.20. U.K. Intravenous Solution Market Forecast, By End-user 13.20.1. Hospitals 13.20.2. Ambulatory Surgery Centers 13.20.3. Home Care Settings 13.21. Germany Intravenous Solution Market Value Share Analysis, By Application 13.22. Germany Intravenous Solution Market Forecast, By Application 13.22.1. Basic IV Solution 13.22.2. Nutritional IV Solution 13.22.3. Blood IV Solution 13.22.4. Drug IV Solution 13.22.5. Irrigation IV Solution 13.22.6. Others 13.23. Germany Intravenous Solution Market Value Share Analysis, By Type 13.24. Germany Intravenous Solution Market Forecast, By Type 13.24.1. Total Parenteral Nutrition (TPN) 13.24.2. Peripheral Parenteral Nutrition (PPN) 13.24.3. Others 13.25. Germany Intravenous Solution Market Value Share Analysis, By Nutrients 13.26. Germany Intravenous Solution Market Forecast, By Nutrients 13.26.1. Carbohydrates 13.26.2. Single dose amino acid solution 13.26.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 13.27. Germany Intravenous Solution Market Value Share Analysis, By End-user 13.28. Germany Intravenous Solution Market Forecast, By End-user 13.28.1. Hospitals 13.28.2. Ambulatory Surgery Centers 13.28.3. Home Care Settings 13.29. France Intravenous Solution Market Value Share Analysis, By Application 13.30. France Intravenous Solution Market Forecast, By Application 13.30.1. Basic IV Solution 13.30.2. Nutritional IV Solution 13.30.3. Blood IV Solution 13.30.4. Drug IV Solution 13.30.5. Irrigation IV Solution 13.30.6. Others 13.31. France Intravenous Solution Market Value Share Analysis, By Type 13.32. France Intravenous Solution Market Forecast, By Type 13.32.1. Total Parenteral Nutrition (TPN) 13.32.2. Peripheral Parenteral Nutrition (PPN) 13.32.3. Others 13.33. France Intravenous Solution Market Value Share Analysis, By Nutrients 13.34. France Intravenous Solution Market Forecast, By Nutrients 13.34.1. Carbohydrates 13.34.2. Single dose amino acid solution 13.34.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 13.35. France Intravenous Solution Market Value Share Analysis, By End-user 13.36. France Intravenous Solution Market Forecast, By End-user 13.36.1. Hospitals 13.36.2. Ambulatory Surgery Centers 13.36.3. Home Care Settings 13.37. Italy Intravenous Solution Market Value Share Analysis, By Application 13.38. Italy Intravenous Solution Market Forecast, By Application 13.38.1. Basic IV Solution 13.38.2. Nutritional IV Solution 13.38.3. Blood IV Solution 13.38.4. Drug IV Solution 13.38.5. Irrigation IV Solution 13.38.6. Others 13.39. Italy Intravenous Solution Market Value Share Analysis, By Type 13.40. Italy Intravenous Solution Market Forecast, By Type 13.40.1. Total Parenteral Nutrition (TPN) 13.40.2. Peripheral Parenteral Nutrition (PPN) 13.40.3. Others 13.41. Italy Intravenous Solution Market Value Share Analysis, By Nutrients 13.42. Italy Intravenous Solution Market Forecast, By Nutrients 13.42.1. Carbohydrates 13.42.2. Single dose amino acid solution 13.42.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 13.43. Italy Intravenous Solution Market Value Share Analysis, By End-user 13.44. Italy Intravenous Solution Market Forecast, By End-user 13.44.1. Hospitals 13.44.2. Ambulatory Surgery Centers 13.44.3. Home Care Settings 13.45. Spain Intravenous Solution Market Value Share Analysis, By Application 13.46. Spain Intravenous Solution Market Forecast, By Application 13.46.1. Basic IV Solution 13.46.2. Nutritional IV Solution 13.46.3. Blood IV Solution 13.46.4. Drug IV Solution 13.46.5. Irrigation IV Solution 13.46.6. Others 13.47. Spain Intravenous Solution Market Value Share Analysis, By Type 13.48. Spain Intravenous Solution Market Forecast, By Type 13.48.1. Total Parenteral Nutrition (TPN) 13.48.2. Peripheral Parenteral Nutrition (PPN) 13.48.3. Others 13.49. Spain Intravenous Solution Market Value Share Analysis, By Nutrients 13.50. Spain Intravenous Solution Market Forecast, By Nutrients 13.50.1. Carbohydrates 13.50.2. Single dose amino acid solution 13.50.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 13.51. Spain Intravenous Solution Market Value Share Analysis, By End-user 13.52. Spain Intravenous Solution Market Forecast, By End-user 13.52.1. Hospitals 13.52.2. Ambulatory Surgery Centers 13.52.3. Home Care Settings 13.53. Rest of Europe Intravenous Solution Market Value Share Analysis, By Application 13.54. Rest of Europe Intravenous Solution Market Forecast, By Application 13.54.1. Basic IV Solution 13.54.2. Nutritional IV Solution 13.54.3. Blood IV Solution 13.54.4. Drug IV Solution 13.54.5. Irrigation IV Solution 13.54.6. Others 13.55. Rest of Europe Intravenous Solution Market Value Share Analysis, By Type 13.56. Rest of Europe Intravenous Solution Market Forecast, By Type 13.56.1. Total Parenteral Nutrition (TPN) 13.56.2. Peripheral Parenteral Nutrition (PPN) 13.56.3. Others 13.57. Rest of Europe Intravenous Solution Market Value Share Analysis, By Nutrients 13.58. Rest of Europe Intravenous Solution Market Forecast, By Nutrients 13.58.1. Carbohydrates 13.58.2. Single dose amino acid solution 13.58.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 13.59. Rest of Europe Intravenous Solution Market Value Share Analysis, By End-user 13.60. Rest of Europe Intravenous Solution Market Forecast, By End-user 13.60.1. Hospitals 13.60.2. Ambulatory Surgery Centers 13.60.3. Home Care Settings 13.61. PEST Analysis 13.62. Key Trends 13.63. Key Developments 14. Asia Pacific Intravenous Solution Market Analysis 14.1. Key Findings 14.2. Asia Pacific Intravenous Solution Market Overview 14.3. Asia Pacific Intravenous Solution Market Value Share Analysis, By Application 14.4. Asia Pacific Intravenous Solution Market Forecast, By Application 14.4.1. Basic IV Solution 14.4.2. Nutritional IV Solution 14.4.3. Blood IV Solution 14.4.4. Drug IV Solution 14.4.5. Irrigation IV Solution 14.4.6. Others 14.5. Asia Pacific Intravenous Solution Market Value Share Analysis, By Type 14.6. Asia Pacific Intravenous Solution Market Forecast, By Type 14.6.1. Total Parenteral Nutrition (TPN) 14.6.2. Peripheral Parenteral Nutrition (PPN) 14.6.3. Others 14.7. Asia Pacific Intravenous Solution Market Value Share Analysis, By Nutrients 14.8. Asia Pacific Intravenous Solution Market Forecast, By Nutrients 14.8.1. Carbohydrates 14.8.2. Single dose amino acid solution 14.8.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 14.9. Asia Pacific Intravenous Solution Market Value Share Analysis, By End-user 14.10. Asia Pacific Intravenous Solution Market Forecast, By End-user 14.10.1. Hospitals 14.10.2. Ambulatory Surgery Centers 14.10.3. Home Care Settings 14.11. Asia Pacific Intravenous Solution Market Value Share Analysis, by Country 14.12. Asia Pacific Intravenous Solution Market Forecast, by Country 14.12.1. China 14.12.2. India 14.12.3. Japan 14.12.4. ASEAN 14.12.5. Rest of Asia Pacific 14.13. China Intravenous Solution Market Value Share Analysis, By Application 14.14. China Intravenous Solution Market Forecast, By Application 14.14.1. Basic IV Solution 14.14.2. Nutritional IV Solution 14.14.3. Blood IV Solution 14.14.4. Drug IV Solution 14.14.5. Irrigation IV Solution 14.14.6. Others 14.15. China Intravenous Solution Market Value Share Analysis, By Type 14.16. China Intravenous Solution Market Forecast, By Type 14.16.1. Total Parenteral Nutrition (TPN) 14.16.2. Peripheral Parenteral Nutrition (PPN) 14.16.3. Others 14.17. China Intravenous Solution Market Value Share Analysis, By Nutrients 14.18. China Intravenous Solution Market Forecast, By Nutrients 14.18.1. Carbohydrates 14.18.2. Single dose amino acid solution 14.18.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 14.19. China Intravenous Solution Market Value Share Analysis, By End-user 14.20. China Intravenous Solution Market Forecast, By End-user 14.20.1. Hospitals 14.20.2. Ambulatory Surgery Centers 14.20.3. Home Care Settings 14.21. India Intravenous Solution Market Value Share Analysis, By Application 14.22. India Intravenous Solution Market Forecast, By Application 14.22.1. Basic IV Solution 14.22.2. Nutritional IV Solution 14.22.3. Blood IV Solution 14.22.4. Drug IV Solution 14.22.5. Irrigation IV Solution 14.22.6. Others 14.23. India Intravenous Solution Market Value Share Analysis, By Type 14.24. India Intravenous Solution Market Forecast, By Type 14.24.1. Total Parenteral Nutrition (TPN) 14.24.2. Peripheral Parenteral Nutrition (PPN) 14.24.3. Others 14.25. India Intravenous Solution Market Value Share Analysis, By Nutrients 14.26. India Intravenous Solution Market Forecast, By Nutrients 14.26.1. Carbohydrates 14.26.2. Single dose amino acid solution 14.26.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 14.27. India Intravenous Solution Market Value Share Analysis, By End-user 14.28. India Intravenous Solution Market Forecast, By End-user 14.28.1. Hospitals 14.28.2. Ambulatory Surgery Centers 14.28.3. Home Care Settings 14.29. Japan Intravenous Solution Market Value Share Analysis, By Application 14.30. Japan Intravenous Solution Market Forecast, By Application 14.30.1. Basic IV Solution 14.30.2. Nutritional IV Solution 14.30.3. Blood IV Solution 14.30.4. Drug IV Solution 14.30.5. Irrigation IV Solution 14.30.6. Others 14.31. Japan Intravenous Solution Market Value Share Analysis, By Type 14.32. Japan Intravenous Solution Market Forecast, By Type 14.32.1. Total Parenteral Nutrition (TPN) 14.32.2. Peripheral Parenteral Nutrition (PPN) 14.32.3. Others 14.33. Japan Intravenous Solution Market Value Share Analysis, By Nutrients 14.34. Japan Intravenous Solution Market Forecast, By Nutrients 14.34.1. Carbohydrates 14.34.2. Single dose amino acid solution 14.34.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 14.35. Japan Intravenous Solution Market Value Share Analysis, By End-user 14.36. Japan Intravenous Solution Market Forecast, By End-user 14.36.1. Hospitals 14.36.2. Ambulatory Surgery Centers 14.36.3. Home Care Settings 14.37. ASEAN Intravenous Solution Market Value Share Analysis, By Application 14.38. ASEAN Intravenous Solution Market Forecast, By Application 14.38.1. Basic IV Solution 14.38.2. Nutritional IV Solution 14.38.3. Blood IV Solution 14.38.4. Drug IV Solution 14.38.5. Irrigation IV Solution 14.38.6. Others 14.39. ASEAN Intravenous Solution Market Value Share Analysis, By Type 14.40. ASEAN Intravenous Solution Market Forecast, By Type 14.40.1. Total Parenteral Nutrition (TPN) 14.40.2. Peripheral Parenteral Nutrition (PPN) 14.40.3. Others 14.41. ASEAN Intravenous Solution Market Value Share Analysis, By Nutrients 14.42. ASEAN Intravenous Solution Market Forecast, By Nutrients 14.42.1. Carbohydrates 14.42.2. Single dose amino acid solution 14.42.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 14.43. ASEAN Intravenous Solution Market Value Share Analysis, By End-user 14.44. ASEAN Intravenous Solution Market Forecast, By End-user 14.44.1. Hospitals 14.44.2. Ambulatory Surgery Centers 14.44.3. Home Care Settings 14.45. Rest of Asia Pacific Intravenous Solution Market Value Share Analysis, By Application 14.46. Rest of Asia Pacific Intravenous Solution Market Forecast, By Application 14.46.1. Basic IV Solution 14.46.2. Nutritional IV Solution 14.46.3. Blood IV Solution 14.46.4. Drug IV Solution 14.46.5. Irrigation IV Solution 14.46.6. Others 14.47. Rest of Asia Pacific Intravenous Solution Market Value Share Analysis, By Type 14.48. Rest of Asia Pacific Intravenous Solution Market Forecast, By Type 14.48.1. Total Parenteral Nutrition (TPN) 14.48.2. Peripheral Parenteral Nutrition (PPN) 14.48.3. Others 14.49. Rest of Asia Pacific Intravenous Solution Market Value Share Analysis, By Nutrients 14.50. Rest of Asia Pacific Intravenous Solution Market Forecast, By Nutrients 14.50.1. Carbohydrates 14.50.2. Single dose amino acid solution 14.50.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 14.51. Rest of Asia Pacific Intravenous Solution Market Value Share Analysis, By End-user 14.52. Rest of Asia Pacific Intravenous Solution Market Forecast, By End-user 14.52.1. Hospitals 14.52.2. Ambulatory Surgery Centers 14.52.3. Home Care Settings 14.53. PEST Analysis 14.54. Key Trends 14.55. Key Developments 15. Middle East and Africa Intravenous Solution Market Analysis 15.1. Key Findings 15.2. Middle East and Africa Intravenous Solution Market Overview 15.3. Middle East and Africa Intravenous Solution Market Value Share Analysis, By Application 15.4. Middle East and Africa Intravenous Solution Market Forecast, By Application 15.4.1. Basic IV Solution 15.4.2. Nutritional IV Solution 15.4.3. Blood IV Solution 15.4.4. Drug IV Solution 15.4.5. Irrigation IV Solution 15.4.6. Others 15.5. Middle East and Africa Intravenous Solution Market Value Share Analysis, By Type 15.6. Middle East and Africa Intravenous Solution Market Forecast, By Type 15.6.1. Total Parenteral Nutrition (TPN) 15.6.2. Peripheral Parenteral Nutrition (PPN) 15.6.3. Others 15.7. Middle East and Africa Intravenous Solution Market Value Share Analysis, By Nutrients 15.8. Middle East and Africa Intravenous Solution Market Forecast, By Nutrients 15.8.1. Carbohydrates 15.8.2. Single dose amino acid solution 15.8.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 15.9. Middle East and Africa Intravenous Solution Market Value Share Analysis, By End-user 15.10. Middle East and Africa Intravenous Solution Market Forecast, By End-user 15.10.1. Hospitals 15.10.2. Ambulatory Surgery Centers 15.10.3. Home Care Settings 15.11. Middle East and Africa Intravenous Solution Market Value Share Analysis, by Country 15.12. Middle East and Africa Intravenous Solution Market Forecast, by Country 15.12.1. South Africa 15.12.2. GCC 15.12.3. Rest of Middle East and Africa 15.13. South Africa Intravenous Solution Market Value Share Analysis, By Application 15.14. South Africa Intravenous Solution Market Forecast, By Application 15.14.1. Basic IV Solution 15.14.2. Nutritional IV Solution 15.14.3. Blood IV Solution 15.14.4. Drug IV Solution 15.14.5. Irrigation IV Solution 15.14.6. Others 15.15. South Africa Intravenous Solution Market Value Share Analysis, By Type 15.16. South Africa Intravenous Solution Market Forecast, By Type 15.16.1. Total Parenteral Nutrition (TPN) 15.16.2. Peripheral Parenteral Nutrition (PPN) 15.16.3. Others 15.17. South Africa Intravenous Solution Market Value Share Analysis, By Nutrients 15.18. South Africa Intravenous Solution Market Forecast, By Nutrients 15.18.1. Carbohydrates 15.18.2. Single dose amino acid solution 15.18.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 15.19. South Africa Intravenous Solution Market Value Share Analysis, By End-user 15.20. South Africa Intravenous Solution Market Forecast, By End-user 15.20.1. Hospitals 15.20.2. Ambulatory Surgery Centers 15.20.3. Home Care Settings 15.21. GCC Intravenous Solution Market Value Share Analysis, By Application 15.22. GCC Intravenous Solution Market Forecast, By Application 15.22.1. Basic IV Solution 15.22.2. Nutritional IV Solution 15.22.3. Blood IV Solution 15.22.4. Drug IV Solution 15.22.5. Irrigation IV Solution 15.22.6. Others 15.23. GCC Intravenous Solution Market Value Share Analysis, By Type 15.24. GCC Intravenous Solution Market Forecast, By Type 15.24.1. Total Parenteral Nutrition (TPN) 15.24.2. Peripheral Parenteral Nutrition (PPN) 15.24.3. Others 15.25. GCC Intravenous Solution Market Value Share Analysis, By Nutrients 15.26. GCC Intravenous Solution Market Forecast, By Nutrients 15.26.1. Carbohydrates 15.26.2. Single dose amino acid solution 15.26.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 15.27. GCC Intravenous Solution Market Value Share Analysis, By End-user 15.28. GCC Intravenous Solution Market Forecast, By End-user 15.28.1. Hospitals 15.28.2. Ambulatory Surgery Centers 15.28.3. Home Care Settings 15.29. Rest of Middle East and Africa Intravenous Solution Market Value Share Analysis, By Application 15.30. Rest of Middle East and Africa Intravenous Solution Market Forecast, By Application 15.30.1. Basic IV Solution 15.30.2. Nutritional IV Solution 15.30.3. Blood IV Solution 15.30.4. Drug IV Solution 15.30.5. Irrigation IV Solution 15.30.6. Others 15.31. Rest of Middle East and Africa Intravenous Solution Market Value Share Analysis, By Type 15.32. Rest of Middle East and Africa Intravenous Solution Market Forecast, By Type 15.32.1. Total Parenteral Nutrition (TPN) 15.32.2. Peripheral Parenteral Nutrition (PPN) 15.32.3. Others 15.33. Rest of Middle East and Africa Intravenous Solution Market Value Share Analysis, By Nutrients 15.34. Rest of Middle East and Africa Intravenous Solution Market Forecast, By Nutrients 15.34.1. Carbohydrates 15.34.2. Single dose amino acid solution 15.34.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 15.35. Rest of Middle East and Africa Intravenous Solution Market Value Share Analysis, By End-user 15.36. Rest of Middle East and Africa Intravenous Solution Market Forecast, By End-user 15.36.1. Hospitals 15.36.2. Ambulatory Surgery Centers 15.36.3. Home Care Settings 15.37. PEST Analysis 15.38. Key Trends 15.39. Key Developments 16. South America Intravenous Solution Market Analysis 16.1. Key Findings 16.2. South America Intravenous Solution Market Overview 16.3. South America Intravenous Solution Market Value Share Analysis, By Application 16.4. South America Intravenous Solution Market Forecast, By Application 16.4.1. Basic IV Solution 16.4.2. Nutritional IV Solution 16.4.3. Blood IV Solution 16.4.4. Drug IV Solution 16.4.5. Irrigation IV Solution 16.4.6. Others 16.5. South America Intravenous Solution Market Value Share Analysis, By Type 16.6. South America Intravenous Solution Market Forecast, By Type 16.6.1. Total Parenteral Nutrition (TPN) 16.6.2. Peripheral Parenteral Nutrition (PPN) 16.6.3. Others 16.7. South America Intravenous Solution Market Value Share Analysis, By Nutrients 16.8. South America Intravenous Solution Market Forecast, By Nutrients 16.8.1. Carbohydrates 16.8.2. Single dose amino acid solution 16.8.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 16.9. South America Intravenous Solution Market Value Share Analysis, By End-user 16.10. South America Intravenous Solution Market Forecast, By End-user 16.10.1. Hospitals 16.10.2. Ambulatory Surgery Centers 16.10.3. Home Care Settings 16.11. South America Intravenous Solution Market Value Share Analysis, by Country 16.12. South America Intravenous Solution Market Forecast, by Country 16.12.1. Mexico 16.12.2. Brazil 16.12.3. Rest of South America 16.13. Mexico Intravenous Solution Market Value Share Analysis, By Application 16.14. Mexico Intravenous Solution Market Forecast, By Application 16.14.1. Basic IV Solution 16.14.2. Nutritional IV Solution 16.14.3. Blood IV Solution 16.14.4. Drug IV Solution 16.14.5. Irrigation IV Solution 16.14.6. Others 16.15. Mexico Intravenous Solution Market Value Share Analysis, By Type 16.16. Mexico Intravenous Solution Market Forecast, By Type 16.16.1. Total Parenteral Nutrition (TPN) 16.16.2. Peripheral Parenteral Nutrition (PPN) 16.16.3. Others 16.17. Mexico Intravenous Solution Market Value Share Analysis, By Nutrients 16.18. Mexico Intravenous Solution Market Forecast, By Nutrients 16.18.1. Carbohydrates 16.18.2. Single dose amino acid solution 16.18.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 16.19. Mexico Intravenous Solution Market Value Share Analysis, By End-user 16.20. Mexico Intravenous Solution Market Forecast, By End-user 16.20.1. Hospitals 16.20.2. Ambulatory Surgery Centers 16.20.3. Home Care Settings 16.21. Brazil Intravenous Solution Market Value Share Analysis, By Application 16.22. Brazil Intravenous Solution Market Forecast, By Application 16.22.1. Basic IV Solution 16.22.2. Nutritional IV Solution 16.22.3. Blood IV Solution 16.22.4. Drug IV Solution 16.22.5. Irrigation IV Solution 16.22.6. Others 16.23. Brazil Intravenous Solution Market Value Share Analysis, By Type 16.24. Brazil Intravenous Solution Market Forecast, By Type 16.24.1. Total Parenteral Nutrition (TPN) 16.24.2. Peripheral Parenteral Nutrition (PPN) 16.24.3. Others 16.25. Brazil Intravenous Solution Market Value Share Analysis, By Nutrients 16.26. Brazil Intravenous Solution Market Forecast, By Nutrients 16.26.1. Carbohydrates 16.26.2. Single dose amino acid solution 16.26.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 16.27. Brazil Intravenous Solution Market Value Share Analysis, By End-user 16.28. Brazil Intravenous Solution Market Forecast, By End-user 16.28.1. Hospitals 16.28.2. Ambulatory Surgery Centers 16.28.3. Home Care Settings 16.29. Rest of South America Intravenous Solution Market Value Share Analysis, By Application 16.30. Rest of South America Intravenous Solution Market Forecast, By Application 16.30.1. Basic IV Solution 16.30.2. Nutritional IV Solution 16.30.3. Blood IV Solution 16.30.4. Drug IV Solution 16.30.5. Irrigation IV Solution 16.30.6. Others 16.31. Rest of South America Intravenous Solution Market Value Share Analysis, By Type 16.32. Rest of South America Intravenous Solution Market Forecast, By Type 16.32.1. Total Parenteral Nutrition (TPN) 16.32.2. Peripheral Parenteral Nutrition (PPN) 16.32.3. Others 16.33. Rest of South America Intravenous Solution Market Value Share Analysis, By Nutrients 16.34. Rest of South America Intravenous Solution Market Forecast, By Nutrients 16.34.1. Carbohydrates 16.34.2. Single dose amino acid solution 16.34.3. Others (Vitamins & minerals,Parenteral lipid emulsion) 16.35. Rest of South America Intravenous Solution Market Value Share Analysis, By End-user 16.36. Rest of South America Intravenous Solution Market Forecast, By End-user 16.36.1. Hospitals 16.36.2. Ambulatory Surgery Centers 16.36.3. Home Care Settings 16.37. PEST Analysis 16.38. Key Trends 16.39. Key Developments 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 17.2.2. New Product Launches and Product Enhancements 17.2.3. Market Consolidation 17.2.3.1. M&A by Regions, Investment and Applications 17.2.3.2. M&A Key Players, Forward Integration and Backward Integration 17.3. Company Profiles: Key Players 17.3.1. Baxter 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Product Portfolio 17.3.1.4. Business Strategy 17.3.1.5. Recent Developments 17.3.1.6. Development Footprint 17.3.2. Fresenius Kabi AG, 17.3.3. B. Braun Melsungen AG, 17.3.4. ICU Medical, Inc., 17.3.5. Grifols, 17.3.6. Terumo Corporation, 17.3.7. Amanta Healthcare, 17.3.8. Ajinomoto, 17.3.9. Johnson & Johnson , 17.3.10. Novartis AG 17.3.11. Abbott Laboratories 17.3.12. Medtronic PLC 17.3.13. Danaher Corporation 17.3.14. General Electric 17.3.15. 3M Company 17.3.16. Siemens Healthineers 17.3.17. Stryker Corporation 17.3.18. Becton, Dickinson & Company 17.3.19. Intuitive Surgical Inc. 17.3.20. Allergan PLC 17.3.21. Hoya Corp.